VP
HNGE

Vitruvian Partners’s Hinge Health HNGE Stock Holding History

Vitruvian Partners’s Portfolio HNGE Stock Details HNGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42M Sell
506,599
-743,401
-59% -$40.4M 20.92% 2
2026
Q1 		$48.2M Hold
1,250,000
– – 43.09% 1
2025
Q4 		$58.1M Hold
1,250,000
– – 41.73% 1
2025
Q3 		$61.4M Hold
1,250,000
– – 42.55% 1
2025
Q2 		$64.7M Buy
+1,250,000
New +$50.5M 39.39% 1

Other funds holding HNGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $205M AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vitruvian Partners's HNGE Position: Q2 2026 in Review

Vitruvian Partners reduced its Hinge Health (HNGE) stake by 59% in Q2 2026, selling an estimated $40.4M and leaving 506,599 shares worth $42M. The position accounts for 20.92% of the portfolio, ranked #2.

Vitruvian Partners first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. The position peaked at $64.7M in Q2 2025. 276 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Vitruvian Partners held 506,599 shares of Hinge Health worth $42M as of Q2 2026.
  • Vitruvian Partners sold 743,401 Hinge Health shares in Q2 2026, an estimated $40.4M.
  • Hinge Health made up 20.92% of Vitruvian Partners's portfolio in Q2 2026, its #2 holding.
  • Vitruvian Partners first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • Vitruvian Partners's Hinge Health position peaked at $64.7M in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Vitruvian Partners's 13F filing for Q2 2026, filed 10 Aug 2026.